MacroGenics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 2,524 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 2,476 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee stock option (right to buy) 2,476 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 2,476 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Employee stock option (right to buy) 6,516 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Common Stock 6,516 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Employee stock option (right to buy) 3,000 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Common Stock 3,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 5,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee stock option (right to buy) 5,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 5,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee stock option (right to buy) 10,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 10,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 10,000 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Common Stock 5,000 N/A N/A
Option
RISSER ERIC BLASIUS officer: Sr VP & Chief Business..
Common Stock 2,000 N/A N/A
Option
RISSER ERIC BLASIUS officer: Sr VP & Chief Business..
Employee stock option (right to buy) 2,000 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Employee stock option (right to buy) 5,000 N/A N/A
Option
BONVINI EZIO officer: Sr VP, Research & CSO
Common Stock 53,264 N/A N/A
Option
BONVINI EZIO officer: Sr VP, Research & CSO
Common Stock 53,264 $1.51 $80,429
Option
BONVINI EZIO officer: Sr VP, Research & CSO
Employee stock option (right to buy) 26,632 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee stock option (right to buy) 5,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 5,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 5,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 15,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 15,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee stock option (right to buy) 15,000 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Employee stock option (right to buy) 5,000 N/A N/A
Option
KARRELS JAMES officer: SVP, CFO and Secretary
Common Stock 5,000 N/A N/A
Option
KOENIG SCOTT director, officer: President an..
Common Stock 79,898 N/A N/A
Option
KOENIG SCOTT director, officer: President an..
Employee stock option (right to buy) 79,898 N/A N/A
Option
BONVINI EZIO officer: Sr VP, Research & CSO
Common Stock 10,698 $0.94 $10,056
Option
BONVINI EZIO officer: Sr VP, Research & CSO
Common Stock 10,698 N/A N/A
Option
BONVINI EZIO officer: Sr VP, Research & CSO
Employee Stock Option (right to buy) 5,349 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee Stock Option (right to buy) 20,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 20,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 20,000 $17.02 $340,400
Sale
CILINSKI LYNN officer: VP, Controller and Tre..
Common Stock 6,231 N/A N/A
Option
CILINSKI LYNN officer: VP, Controller and Tre..
Common Stock 6,231 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee Stock Option (right to buy) 20,000 $4.7 $94,000
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 10,000 N/A N/A
Option
CILINSKI LYNN officer: VP, Controller and Tre..
Employee Stock Option (right to buy) 2,237 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee Stock Option (right to buy) 20,000 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 20,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 20,000 N/A N/A
Option
CILINSKI LYNN officer: VP, Controller and Tre..
Employee Stock Option (right to buy) 4,501 N/A N/A
Sale
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 5,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Employee Stock Option (right to buy) 5,000 N/A N/A
Option
WIGGINTON JON MARC officer: Sr VP, Clinical Dev. &..
Common Stock 5,000 N/A N/A
Option
CILINSKI LYNN officer: VP, Controller and Tre..
Common Stock 8,922 N/A N/A

Showing 250 to 300 of 453 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.